Fluvoxamine for the treatment of COVID-19.

Details

Ressource 1Download: 35180411_BIB_A6D6B687283D.pdf (98.79 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_A6D6B687283D
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
UNIL/CHUV
Title
Fluvoxamine for the treatment of COVID-19.
Journal
The Lancet. Global health
Author(s)
Marzolini C., Marra F., Boyle A., Khoo S., Back D.J.
ISSN
2214-109X (Electronic)
ISSN-L
2214-109X
Publication state
Published
Issued date
03/2022
Peer-reviewed
Oui
Volume
10
Number
3
Pages
e331
Language
english
Notes
Publication types: Letter ; Comment
Publication Status: ppublish
Keywords
Fluvoxamine/therapeutic use, Humans, SARS-CoV-2, COVID-19 Drug Treatment
URN
urn:nbn:ch:serval-BIB_A6D6B687283D1
OAI-PMH
oai:serval.unil.ch:BIB_A6D6B687283D
DOI
10.1016/S2214-109X(21)00592-1
Pubmed
35180411
Web of science
000759561600018
Open Access
Yes
Create date
25/08/2023 5:17
Last modification date
06/08/2024 6:02
Usage data